Skip to main content

Want a detailed portfolio tracker?

Burning Rock Biotech (BNR) P/E (2020 - 2026)

Burning Rock Biotech (BNR) P/E from Jun 12, 2020 to Jun 2, 2026. The TTM Burning Rock Biotech (BNR) P/E is -0.99. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Burning Rock Biotech (BNR)

YearP/EChange
2026-0.99-52.16%
2025-2.08+198.52%
2024-0.70-27.42%
2023-0.96-58.67%
2022-2.32-76.39%
2021-9.82-58.74%
2020-23.80N/A

Comparison Burning Rock Biotech (BNR) P/E with competitors

Burning Rock Biotech (BNR) P/E is -0.99.

TickerNameP/EUpside
ADVBAdvanced Biomed Inc0.78-178.46%
MBAICheckCap Ltd2.88-390.20%
FONRFonar Corp15.41-1651.60%
QGENQiagen NV17.55-1866.48%
IQVIQVIA Holdings Inc20.25-2138.52%
DGXQuest Diagnostics Inc21.62-2276.42%
LHLaboratory Corp Of America Holdings22.66-2381.36%
AAgilent Technologies Inc25.45-2661.89%
MEDPMedpace Holdings Inc26.32-2749.93%
TMOThermo Fisher Scientific Inc26.87-2805.01%
MTDMettler-Toledo International Inc26.96-2814.07%
DHRDanaher Corp33.26-3447.84%
ILMNIllumina Inc34.97-3620.64%
ICLRIcon Plc39.55-4080.96%
IDXXIdexx Laboratories Inc40.14-4140.34%
VCYTVeracyte Inc40.15-4142.27%
RVTYRevvity Inc45.79-4709.76%
SHCSotera Health Company63.43-6485.34%
WATWaters Corp93.81-9543.51%